Citations

Mayo Clinic

Showing 10 of 108522 citations.

Trends in Transcatheter Aortic Valve Implantation Utilization, Outcomes, and Healthcare Resource Use in Patients With Liver Cirrhosis: A Decade of Insights (2011–2020)
Krittanawong, Chayakrit , Qadeer, Yusuf Kamran , Chen, Bing , Al-Azzam, Fu’ad, Sharma, Samin K. , Jneid, Hani , Wang, Yichen , Wang, Zhen , Alam, Mahboob

Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine | August 23, 2024 | Volume: 23 | Issue: 3 | Pages: 166-173

10.1097/hpc.0000000000000361 | PMID 38598544 Get It

It is well known that individuals with liver cirrhosis are considered at high risk for cardiac surgery, with an increased risk for morbidity and mortality as the liver disease progresses. In the last decade, there have been considerable advances in transcatheter aortic valve implantation (TAVI) as an alternative to surgical aortic valve replacement (SAVR) in individuals deemed to be at high risk for surgery. However, research surrounding TAVI in the setting of liver cirrhosis has not been as widely studied. In this national population-based cohort study, we evaluated the trends of mortality, complications, and healthcare utilization in liver cirrhotic patients undergoing TAVI, as well as analyzed the basic demographics of these individuals. We found that from 2011 to 2020, the amount of TAVI procedures conducted in cirrhotic patients was increasing annually, while mortality, procedural complications, and healthcare utilization trends in these cirrhotic patients undergoing TAVI decreased. Overall, TAVI does seem to be reasonable management for aortic stenosis patients with liver cirrhosis who need aortic valve replacement.
Patient Opportunities to Self-Schedule in a Large Multisite, Multispecialty Medical Practice: Program Description and Uptake of 7 Unique Processes for Patients to Successfully Self-Schedule (and Reschedule) Their Medical Appointments
North, Frederick , Buss, Rebecca J , Nelson, Elissa M , Thompson, Matthew C , Crum, Brian A. , Buss, Rebecca , Pecina, Jennifer , Crum, Brian A , Thompson, Matthew C , Pecina, Jennifer L.

Health Services Research and Managerial Epidemiology | August 23, 2024 | Volume: 11 | Issue: No issue available | Pages: No page available

10.1177/23333928241271933 | PMID 39185323 Get It

Introduction Patient self-scheduling of medical appointments is becoming more common in many medical institutions. However, the complexity of scheduling multiple specialties, following scheduling guidelines, and managing appointment access requires a variety of processes for a diverse inventory of self-schedulable appointment types. Methods From 7 unique patient self-scheduling methods, we captured counts of successfully self-scheduled and completed appointments. A process map was created to show the paths of 5 different primary self-scheduling processes (new appointment self-scheduling) and 2 secondary self-scheduling processes (existing appointment self-rescheduling). Results There were 7 unique processes that led to 733,651 successfully self-scheduled completed visits from January 1 to December 31, 2023 at a multisite, multispecialty clinic. The self-scheduling processes consisted of the following: (1) Ticket offer (appointment “ticket” offers for specific visits generated by a provider order or system rules), the software “ticket” sent to the patient permits “admission” to self-schedule calendar templates (341,591 uses, 46.6%); (2) direct self-scheduled visit for prequalified visit types (203,593 uses, 27.6%); (3) self-reschedule option (patient option to reschedule existing appointment, 79,706 uses, 10.9%); (4) new patient self-scheduled visit via clinic website (does not require portal access, 54,367 uses, 7.4%). (5) automated waitlist self-rescheduled visit (38,649 uses, 5.3%); (6) automated waitlist self-scheduled visit of previously unscheduled visit (10,939 uses, 1.5%); and (7) self-triage self-scheduled visit (4806 uses, 0.7%). Conclusion The processes for self-scheduling are expanding. Our multispecialty clinic has implemented 7 different processes to help patients successfully self-schedule medical appointments. Some of the processes occur before initial scheduling (such as self-triage), and some are implemented after successful scheduling has already occurred (self-rescheduling option and self-rescheduling aided by an automated waitlist). Continued research is needed to look for measures of success beyond the ability to complete a self-scheduled visit, including the accuracy of the booking (right provider, location, and length of visit).
Clinical Outcomes of Cardiogenic Shock Due to Spontaneous Coronary Artery Dissection Versus Cardiogenic Shock Due to Coronary Artery Disease
Krittanawong, Chayakrit , Qadeer, Yusuf Kamran , Sharma, Samin K. , Jneid, Hani , Ang, Song Peng , Wang, Zhen , Alam, Mahboob

Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine | August 23, 2024 | Volume: 23 | Issue: 3 | Pages: 141-148

10.1097/hpc.0000000000000354 | PMID 38467033 Get It

Spontaneous coronary artery dissection (SCAD) can be treated conservatively. However, some SCAD patients can develop cardiogenic shock (CS). We evaluated the outcomes of SCAD-related CS using data from a national population-based cohort study from January 1, 2016, to December 30, 2019. In our study of 32,640 patients with SCAD, about 10.6% of patients presented with CS. We found that SCAD patients with CS had higher mortality and greater complications including use of mechanical circulatory devices, arrhythmias, respiratory support, and acute heart failure compared to those without CS. When comparing CS due to SCAD with that due to coronary artery disease, we found that although mortality rates were similar, those with CS due to SCAD were associated with higher risk of use of mechanical circulatory support, major bleeding, blood transfusion, and respiratory failure.
Abusive Pediatric Burns Module in the Child Abuse Pediatrics Curriculum for Physicians (CAP-CuP)
Johnson, Katie L. , Crumm, Caitlin E. , Brown, Emily , Johnson, Katie

MedEdPORTAL | August 23, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.15766/mep_2374-8265.11429 | PMID 39184363 Get It

What Free Flaps Are Surgeons Using for Palatal Fistula Repair in Patients with Cleft Palate? A Systematic Review
Zheng, Eugene E. , Gates-Tanzer, Lauren, Cherukuri, Sai , Bite, Uldis, Gibreel, Waleed , Gibreel, Waleed , Mardini, Samir , Murad, M. Hassan

The Cleft Palate Craniofacial Journal | August 23, 2024 | Volume: 62 | Issue: 9 | Pages: 1568-1577

10.1177/10556656241266243 | PMID 39175361 Get It

Objective Recalcitrant palatal fistulas in patients with cleft palate history sometimes require free flap reconstruction. This study reviews the literature on described flaps and outcomes. Design A systematic review was conducted per the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Setting All study designs were included. Non-English articles were excluded. Patients and Participants Patients with a history of cleft palate who underwent free flap reconstruction for a oronasal fistula. Interventions Free tissue transfer for a palatal fistula repair. Main outcomee measures Information regarding defect and flap characteristics were reviewed. Surgical outcomes such as flap loss rates, rates of recurrent fistula formation, and speech outcomes were also obtained. Results Our search returned 894 articles, of which 23 were included. All studies were retrospective case series and reports. A total of 65 patients were described with an average age of 19.3 (range 3–55) years and a median fistula size of 8.00 cm 2 (range 2.54 cm 2 – 24 cm 2 ). The most common flap was the radial forearm flap (n = 37). Nine patients (13.8%) had recurrent fistula formation with surgical revision successful in all cases in which the patient returned to the operating room. There were two partial flap losses and no total flap losses. Speech outcomes showed improvement in 27 patients across 10 studies. Conclusions Palatal fistula repair with free tissue transfer is safe with an acceptable risk profile and low flap loss rate. Early recurrence due to partial flap necrosis and dehiscence are successfully managed with flap readvancement.
PUNCH CD3-OLS: A Phase 3 Prospective Observational Cohort Study to Evaluate the Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA) in Adults With Recurrent Clostridioides difficile Infection
Feuerstadt, Paul , Knapple, W , Hise, Nicholas W. Van, Baggott, Brian, Guthmueller, Beth, Bancke, Lindy, Gamborg, Michael, Steiner, Theodore S. , Handel, Daniel Van, Khanna, Sahil , Khanna, S , Feuerstadt, Paul , Chopra, Teena , Dubberke, Erik R.

Clinical Infectious Diseases | August 23, 2024 | Volume: 80 | Issue: 1 | Pages: 43-51

10.1093/cid/ciae437 | PMID 39180326 Get It

Abstract Background The aim of this study was to evaluate the safety and efficacy of fecal microbiota, live-jslm (RBL; REBYOTA)—the first single-dose, broad consortia microbiota-based live biotherapeutic approved by the US Food and Drug Administration for preventing recurrent Clostridioides difficile infection (rCDI) in adults following standard-of-care (SOC) antibiotic treatment. Methods PUNCH CD3-OLS was a prospective, phase 3, open-label study, conducted across the US and Canada. Participants were aged ≥18 years with documented rCDI and confirmed use of SOC antibiotics. Participants with comorbidities including inflammatory bowel disease and mild-to-moderate immunocompromising conditions could be enrolled. A single dose of RBL was rectally administered within 24–72 hours of antibiotic completion. The primary endpoint was the number of participants with RBL- or administration-related treatment-emergent adverse events (TEAEs). Secondary endpoints included treatment success and sustained clinical response, at 8 weeks and 6 months after RBL administration, respectively. Results Overall, 793 participants were enrolled, of whom 697 received RBL. TEAEs through 8 weeks after administration were reported by 47.3% of participants; most events were mild or moderate gastrointestinal disorders. Serious TEAEs were reported by 3.9% of participants. The treatment success rate at 8 weeks was 73.8%; in participants who achieved treatment success, the sustained clinical response rate at 6 months was 91.0%. Safety and efficacy rates were similar across demographic and baseline characteristic subgroups. Conclusions RBL was safe and efficacious in participants with rCDI and common comorbidities. This is the largest microbiota-based live biotherapeutic study to date, and findings support use of RBL to prevent rCDI in a broad patient population. Clinical Trials Registration NCT03931941.
Liver transplantation for pediatric genetic and metabolic disorders
Hassan, Sara , Anouti, Ahmad , Tan, Queenie K-G , Wangensteen, Kirk J. , Aqul, Amal , Tan, Queenie K.‐G. , Aqul, Amal , Wangensteen, Kirk J , Hassan, Sara

Liver Transplantation | August 23, 2024 | Volume: 31 | Issue: 6 | Pages: 803-814

10.1097/lvt.0000000000000454 | PMID 39171972 Get It

Pediatric genetic and metabolic liver diseases comprise a broad spectrum of conditions and represent the second most common indication for liver transplantation following biliary atresia. The decision to transplant can be challenging and requires consideration of several factors, including hepatic involvement, extrahepatic manifestations, and anticipated posttransplant outcomes. This review examines pediatric genetic and metabolic liver diseases, their pathophysiology, clinical presentation, and the role of liver transplantation.
Congestive colopathy in a patient with arteriovenous malformations and multiple mesenteric thromboses
Gawey, Brent J. , Andrews, James C., Bledsoe, Adam C. , Gawey, Brent , Andrews, James C

BMJ Case Reports | August 23, 2024 | Volume: 17 | Issue: 8 | Pages: e261713

10.1136/bcr-2024-261713 | PMID 39179262 Get It

Arteriovenous malformations (AVMs) in mesenteric vessels are exceptionally rare. These congenital vascular anomalies lead to direct vascular flow between the highly pressured arterial system and the low-pressure venous system. We describe the case of a patient with prior left colectomy for splenic flexure colonic adenocarcinoma presenting with persistent abdominal pain after developing multiple mesenteric thromboses. CT and colonoscopy showed left hemicolon congestion, anastomotic stenosis and mucosal oedema. Mesenteric angiogram revealed AVMs in the right colic and left colic arteries. Embolisation of the left colic AVM led to symptom resolution without recurrence at interval follow-up.
Teaching NeuroImage: Hydrocephalus and Ischemic Stroke in an Infant With a Glioneuronal Tumor
Liu, Michael , Vasquez, Alejandra , Keating, Gesina F. , Youssef, Paul E., Liu, Michael , Raghunathan, Aditya , Youssef, Paul, Syc‐Mazurek, Stephanie B. , Raghunathan, Aditya

Neurology | August 23, 2024 | Volume: 103 | Issue: 6 | Pages: No page available

10.1212/wnl.0000000000209791 | PMID 39167751 Get It

Teaching Video NeuroImage: Isolated Presentation of Cavernous Sinus Syndrome From CNS Lymphoma
Itoh, Christopher Y. , Griffin, Kim J. , Yi, Dongni , Hooshmand, Sara , Webb, Lauren M. , Giannini, Caterina , Graff‐Radford, Jonathan , Mustafa, Rafid , Hooshmand, Sara J , Giannini, Caterina , Mustafa, Rafid , Itoh, Christopher Yuki

Neurology | August 23, 2024 | Volume: 103 | Issue: 6 | Pages: No page available

10.1212/wnl.0000000000209767 | PMID 39167749 Get It